This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
QP-Brain
A decision support tool to assess MRI brain scans. CE certification and FDA 510(k) clearance are in progress.
An AI-driven MRI solution
QP-Brain® is the leading medical software solution designed to revolutionize the analysis of brain MRI exams. Our AI-driven solution streamlines the analysis of MR images and provides quantitative information to support clinical workflows, all through a fully automatic process. Radiologists and other healthcare professionals can now easily access valuable insights into brain tissue, thanks to QP-Brain’s cutting-edge technology.
By automating image processing tasks, QP-Brain® enhances the diagnostic process. Integrating seamlessly with PACS, QP-Brain® also reduces image processing time, allowing healthcare professionals to maximize their time and resources. QP-Brain provides quantitative and qualitative findings and imaging data, making it an invaluable tool for healthcare professionals.
The challenge
Clinical Overview
Neurodegenerative diseases affect millions of people worldwide. Qualitative assessments to detect early changes are in great demand. Multidisciplinary teams require quantitative information to track changes over time. To accurately track changes in brain atrophy, a qualitative assessment is necessary to compare an individual’s brain with a database of healthy brains.
User needs
-
A tool that performs data quality check (T1 for volumetry, FLAIR for WMH) to ensure optimal analysis
-
A standardized process to increase reproducibility.
-
Detect early and subtle changes.
-
Quantitative information for a more personalized follow-up.
-
Compare volumes with a normative database and quickly identify patients with a high risk of neurodegenerative diseases.
-
Outputs visual guidance and reports for easy analysis and use in multidisciplinary teams.
“Nine million people in Europe have been diagnosed with a neurodegenerative disease”
– Panel discussion in the European Parliament report, Brussels.
The solution
Brain volumetry is a medical imaging technique used to measure the volume of brain regions, aiding in diagnosing and monitoring neurological conditions such as Alzheimer’s disease and multiple sclerosis. It provides valuable quantitative information about brain structures, allowing for earlier detection and better management of disease progression.
White matter hyperintensities (WMHs) are areas of increased signal intensity on MRI scans indicating brain damage or injury to white matter. They are associated with neurological conditions like stroke, multiple sclerosis, and dementia. Tools that detect WMHs aid in the clinical assessment and monitoring of these conditions by providing information about the location, size, and progression of WMHs.
The clinical use of detection tools such as brain volumetry and detection of WMHs supported by a medical imaging software solution such as QP-Brain® automatizing the process improves the efficiency of the clinical workflow, ultimately leading to better patient care.
QP-Brain® is a fully automated MR post-processing software that uses 3D T1 MRI scans for quantitative brain imaging analysis and automatic region segmentation. It performs a quality check of input data and detects white matter hyperintensities (WMHs) in the brain using FLAIR scans. QP-Brain® measures brain regions to detect subtle alterations and provides a range of quantitative information, making it an essential tool for quantitative reporting in diagnostic and follow-up processes in neurological disorders. It increases objectivity and compares volumes with a normative database. QP-Brain® seamlessly integrates with PACS and outputs in DICOM format, making extracting critical findings and using them in multidisciplinary team discussions easier.
Workflow
